ML188
CAS: 1417700-13-0
Ref. 3D-BM178806
5mg | 1.216,00 € | ||
10mg | 1.540,00 € | ||
25mg | 2.269,00 € | ||
50mg | 2.755,00 € | ||
100mg | 4.211,00 € |
Produktinformation
ML188 is a covalent inhibitor of the mammalian target of rapamycin (mTOR). It was originally developed as an anti-cancer drug, but has also shown efficacy in treating autoimmune diseases and bowel disease. ML188 binds to the ATP-binding site of mTOR, which prevents the formation of complex 1, leading to its inhibition. This binding leads to a decrease in proinflammatory cytokines and chemokines such as TNFα, IL-6, and IL-12. The binding of ML188 is reversible, with dissociation constants in the low nanomolar range. The binding of ML188 leads to decreased expression levels for cyclin D1, c-Myc, p21 and p27 proteins. ML188 also inhibits growth factor activity by preventing phosphorylation of Akt/PI3K. In addition to inhibiting mTOR activity, ML188 may inhibit protein synthesis by interfering with ribosomal function.
ML188 has been shown to be effective
Chemische Eigenschaften
Technische Anfrage zu: 3D-BM178806 ML188
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.